Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of [14C] APD421 in Healthy Males
NCT02881840Phase 1Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Aug 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of amisulpride in postoperative nausea and vomiting (PONV), sponsored by Acacia Pharma Group Plc. Primary endpoint: Mass Balance Recovery at 168 hours. Started Aug 2016; status: completed.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02881840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881840.